Published in Langenbecks Arch Surg on August 01, 1999
Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol (2011) 1.63
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases. Br J Cancer (2012) 1.13
Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy. Ann Surg Oncol (2011) 1.01
Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Am J Pathol (2007) 0.98
Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg (2007) 0.91
Factors influencing outcome after surgery for stage IV colorectal cancer. Surg Today (2008) 0.85
Adequate symptom relief justifies hepatic resection for benign disease. BMC Surg (2005) 0.84
Accuracy of frozen section in the diagnosis of liver mass lesions. J Clin Pathol (2006) 0.80
Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases. Ann Surg Oncol (2010) 0.79
Remarkable inhibitory effects of hybrid liposomes on growth of human colon cancer cells through induction of cell cycle arrest along with apoptosis. Int J Nanomedicine (2011) 0.79
Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis. World J Surg Oncol (2015) 0.78
Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival. Med Sci Monit (2012) 0.77
Sequential surgical resection of hepatic and pulmonary metastases from colorectal cancer. Langenbecks Arch Surg (2010) 0.77
Utility of preoperative imaging in evaluating colorectal liver metastases declines over time. HPB (Oxford) (2010) 0.77
Surgical options for initially unresectable colorectal liver metastases. HPB Surg (2012) 0.77
Superiority of combined chemo-embolization and portal infusion with 5-fluorouracil over locoregional infusion concepts in Novikoff hepatoma-bearing rats. J Cancer Res Clin Oncol (2003) 0.76
Characterization of the frequency distribution for human hematogenous metastases: evidence for clustering and a power variance function. Clin Exp Metastasis (2000) 0.76
Optimal management of colorectal liver metastases in older patients: a decision analysis. HPB (Oxford) (2014) 0.75
Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy. World J Surg (2016) 0.75
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg (1990) 4.36
Factors influencing the natural history of colorectal liver metastases. Lancet (1994) 3.61
Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery (1991) 3.35
Correlation of polypoid lesions in the distal colorectum and proximal colon in asymptomatic screening subjects. Eur J Gastroenterol Hepatol (1996) 1.45
[Resection of colorectal liver metastases. What prognostic factors determine patient selection?]. Chirurg (2001) 1.44
Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver. Endoscopy (1997) 1.42
[Operation technique determines frequency of recurrence of colorectal carcinoma]. Chirurg (1999) 1.40
Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis (2004) 1.33
Prognosis of gastric carcinoid tumours. Digestion (1995) 1.23
Risk of invasive carcinoma in colorectal adenomas assessed by size and site. Int J Colorectal Dis (1997) 1.21
Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol (1998) 1.21
Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys (1990) 1.17
Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy (1997) 1.14
Resection of colorectal liver metastases revisited. J Gastrointest Surg (2006) 1.10
[Organ-preserving therapy in invasive bladder carcinoma]. Dtsch Med Wochenschr (1992) 1.06
Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg (1998) 1.03
Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Int J Radiat Oncol Biol Phys (1999) 0.98
[Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions]. Swiss Surg (1996) 0.96
Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys (1994) 0.94
Tumor implantation from needle biopsy of hepatic metastases. Hepatogastroenterology (1990) 0.92
Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature. J Cancer Res Clin Oncol (2013) 0.86
Improvements in staging of gastric carcinoma from using the new edition of TNM classification. Eur J Surg Oncol (1998) 0.85
[Spontaneous splenic rupture in metastatic malignant melanoma]. Zentralbl Chir (2001) 0.85
[Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis]. Chirurg (1995) 0.82
[Carcinoid tumors of the stomach in atrophic autoimmune gastritis: classification, differential diagnosis and prognosis]. Verh Dtsch Ges Pathol (1996) 0.81
Pulmonary resection for metastatic colon and upper rectum cancer. Is it useful? Dis Colon Rectum (1990) 0.80
[Locally recurrent and metastatic malignant melanoma. Long-term results and prognostic factors after percutaneous radiotherapy]. Strahlenther Onkol (1999) 0.80
Sustained renal response to mycophenolate mofetil and CNI taper promotes survival in liver transplant patients with CNI-related renal dysfunction. Dig Dis Sci (2010) 0.79
Differences between colorectal adenomas removed endoscopically and surgically. Hepatogastroenterology (1997) 0.79
[Poorly differentiated neuroendocrine small-cell carcinoma of the gallbladder]. Zentralbl Chir (2011) 0.79
[Evaluation of the "new" TNM classification of head and neck tumors in 3247 patients]. HNO (1999) 0.79
[Update from the soft tissue tumour registry in Jena]. Pathologe (2011) 0.79
Enoral/transoral surgery of malignancies of the oral cavity and the oropharynx. Adv Otorhinolaryngol (1995) 0.78
Head and neck in situ carcinoma: survival analysis of the Thuringian cancer registration database. Oral Oncol (2010) 0.78
Staging of resectable colorectal liver metastases. Surgery (1996) 0.78
Brachial plexus lesions following median sternotomy in cardiac surgery. Thorac Cardiovasc Surg (1991) 0.78
[Prospective study of diagnosis, therapy and follow-up of acute gastrointestinal hemorrhage in 397 patients]. Wien Klin Wochenschr (1996) 0.78
[Adenocarcinoma of small bowel. An underdiagnosed disease]. Chirurg (2012) 0.77
[Symptomatic non-parasitic liver cysts: early and long-term results of surgical management]. Zentralbl Chir (2009) 0.77
[Incidence of non-metastatic liver lesions in tumor patients: consequences for chemotherapy and local ablative procedures]. Chirurg (2014) 0.77
[Simultaneous radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in advanced head and neck tumors]. Strahlenther Onkol (1991) 0.76
[Comparative study of oncological outcome quality in colorectal carcinoma--ranking by surrogate endpoint?]. Chirurg (1999) 0.76
Prognostic value of S-phase fraction in head and neck squamous cell carcinomas and nodal negative breast carcinomas. Strahlenther Onkol (1994) 0.76
[Prognostic relevance of biological and molecular markers in oncology. Criteria for planning and interpreting studies]. Chirurg (2003) 0.75
[Long term results following radiation therapy of locally recurrent and metastatic malignant melanoma]. Hautarzt (1999) 0.75
[Regional chemotherapy of diffuse liver metastases of colorectal cancer]. Zentralbl Chir (1991) 0.75
[Therapy results of locoregional recurrences in rectal cancer]. Zentralbl Chir (2001) 0.75
[Classification and prognosis of supravesical urothelioma with the new TNM classification]. Urologe A (1994) 0.75
[Resection of lung metastases of colorectal cancer. Indications and indication limits]. Zentralbl Chir (1989) 0.75
[Tyrosine kinases in soft tissue tumors]. Pathologe (2014) 0.75
[Lymph node dissections in malignant melanoma]. Chirurg (1996) 0.75
[Curative interventions for recurrence of gastrointestinal carcinomas--incidence and prognosis]. Langenbecks Arch Chir Suppl Kongressbd (1996) 0.75
[Type I or IIa early stomach carcinoma. Comparative studies of the prognosis following limited or radical therapy]. Leber Magen Darm (1990) 0.75
[Surgical interventions in liver metastases]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir (1990) 0.75
[Is surgical therapy of distant metastases of malignant melanoma worthwhile?]. Langenbecks Arch Chir Suppl Kongressbd (1996) 0.75
[Practical goals of data processing in tumor surgery]. Chirurg (1989) 0.75